MAPT and Alzheimer disease: The major hypothesis implicates the defective cleavage of amyloid precursor protein (APP) and the consequent amyloid beta plaque formation as a predominant basis for Alzheimer’s disease, giving rise to a downstream cascade that leads to tau-pathology [12].